Esperion Therapeutics Inc. PS Ratio 2013–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Current and historical P/S ratio for Esperion Therapeutics Inc. (ESPR): market cap divided by trailing twelve-month revenue. As of March 31, 2026 it is 2.19.

From: 03/31/2020To: 03/31/2026

Stock Price

TTM Revenue

PS Ratio

Esperion Therapeutics Inc. PS Ratio — FAQ

Esperion Therapeutics Inc. (ESPR) ps ratio over the last 8 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ESPR's ps ratio history?

The chart and table above show Esperion Therapeutics Inc.'s ps ratio by year and by quarter, including the growth rate.